Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours

British Journal of Cancer, Published online: 18 November 2021; doi:10.1038/s41416-021-01632-2Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research